In a statement on Thursday, S&P Dow Jones Indices said Moderna will join the S&P 500 index as of the start of trading on July 21, replacing Alexion Pharmaceuticals, as reported by Investing.com.
Moderna shares rose 6% in extended trade following the announcement.
Last December, AstraZeneca announced it would acquire Alexion in a $39 billion deal.










(All Rights Reserved)